Prior work from our lab has demonstrated that treatment of human prostate cancer cell lines with epigenetic modifying agents (EMAs) can lead to expression of other SSX family members, including SSX3, SSX5, and SSX8 [14]. Here, SSX3 is linked to Familial prostate cancer.